NP/PA Connect
News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
Publication
Dermatology Times
More
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
    • Biologic Treatments for Moderate to Severe Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
    • Emerging Therapies Plaque Psoriasis
    • Treatments for Plaque Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Skin Cancer (Nonmelanoma)
  • Vitiligo
  • Wound Care
Spotlight -
Derm NP/PA Connect
Advertisement

Valerija Misev, M.D.

Advertisement

Articles by Valerija Misev, M.D.

Clinical trial

Optimize clinical trial recruitment with digital platforms

ByBruce E. Katz, M.D.,Aleksander Eiken, M.D.,Valerija Misev, M.D.,John Robert Zibert, M.SC., Ph.D
January 4th 2019

Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.

Advertisement

Latest Updated Articles

  • Clinical trial
    Optimize clinical trial recruitment with digital platforms

    Published: January 4th 2019 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity

2

Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS

3

Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026

4

FDA Feedback Supports BLA Pathway for Sonelokimab in HS

5

Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us